Stage-specific profiling of Plasmodium falciparum proteases using an internally quenched multispecificity protease substrate

Biochemical and Biophysical Research Communications

Volumn 309, Issue 4, 2003, Pages 974-979

  Pattanaik, Priyaranjan ^a   Jain, Bimba ^a   Ravindra, Gudihal ^b   Gopi, Hosahudya N ^b   Pal, Prajna P ^b   Balaram, Hemalatha ^a   Balaram, Padmanabhan ^b  

^a JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

Fluorescence resonance energy transfer; Fluorescent protease substrate; Malarial proteases; Mass spectrometry; Plasmodium falciparum; Hairpin peptide

Indexed keywords

4 (4 DIMETHYLAMINOPHENYLAZO)BENZOIC ACID; 5 (2 AMINOETHYLAMINO)NAPHTHALENE 1 SULFONIC ACID; BENZOIC ACID DERIVATIVE; PROTEINASE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACIDITY; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENERGY TRANSFER; ENZYME ACTIVITY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPECTROFLUOROMETRY; SYNTHESIS;

PLASMODIUM FALCIPARUM;

EID: 0141453245     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.108     Document Type: Article

References (41)

1. Klemba M., Goldberg D.E. Biological roles of proteases in parasitic protozoa. Annu. Rev. Biochem. 71:2002;275-305.
2. Pattanaik P., Raman J., Balaram H. Perspectives in drug design against malaria. Curr. Top. Med. Chem. 2:2002;483-505.
3. Olliaro P.L., Yuthavong Y. An overview of chemotherapeutic targets for antimalarial drug discovery. Pharmacol. Ther. 81:1999;91-110.
4. Francis S.E., Sullivan D.J. Jr., Goldberg D.E. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:1997;97-123.
5. Blackman M.J. Proteases involved in erythrocyte invasion by the malaria parasite: function and potential as chemotherapeutic target. Curr. Drug Targets. 1:2000;59-83.
6. Gluzman I.Y., Francis S.E., Oksman A., Smith C.E., Duffin K.L., Goldberg D.E. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J. Clin. Invest. 93:1994;1602-1608.
7. Goldberg D.E. Plasmodial hemoglobin degradation: an ordered pathway in a specialized organelle. Infect. Agents Dis. 1:1992;207-211.
8. Luker K.E., Francis S.E., Gluzman I.Y., Goldberg D.E. Kinetic analysis of plasmepsins I and II, aspartic proteases of the Plasmodium falciparum digestive vacuole. Mol. Biochem. Parasitol. 79:1996;71-78.
9. Moon R.P., Tyas L., Certa U., Rupp K., Bur D., Jacquet C., Matile H., Loetscher H., Grueninger-Leitch F., Kay J., Dunn B.M., Berry C., Radley R.G. Expression and characterisation of plasmepsin I from Plasmodium falciparum. Eur. J. Biochem. 244:1997;552-560.
10. Wayatt D.M., Berry C. Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum. FEBS Lett. 513:2002;159-162.
11. Banerjee R., Liu J., Beatty W., Pelosof L., Klemba M., Goldberg D.E. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc. Natl. Acad. Sci. USA. 99:2002;990-995.
12. Salas F., Fichmann J., Lee G.K., Scott M.D., Rosenthal P.J. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect. Immun. 63:1995;2120-2125.
13. Shenai B.R., Sijwali P.S., Singh A., Rosenthal P.J. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 275:2000;29000-29010.
14. Sijwali P.S., Shenai B.R., Gut J., Singh A.J., Rosenthal P.J. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 360:2001;481-489.
15. Eggleson K.K., Duffin K.L., Goldberg D.E. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J. Biol. Chem. 274:1999;32411-32417.
16. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
17. Karle I.L., Awasthi S.K., Balaram P. A designed beta-hairpin peptide in crystals. Proc. Natl. Acad. Sci. USA. 93:1996;8189-8193.
18. Venkatraman J., Shankaramma S.C., Balaram P. Chem. Rev. 101:2001;3131-3152.
19. Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Annu. Rev. Biochem. 47:1978;819-846.
20. Fairclough R.H., Cantor C.R. The use of singlet-singlet energy transfer to study macromolecular assemblies. Methods Enzymol. 48:1978;347-379.
21. Cheung H.C. Lakowicz J.R. Topics in Fluorescence Spectroscopy. vol. 2:1991;218-286 Plenum, New York.
22. Matayoshi E.D., Wang G.T., Krafft G.A., Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 247:1990;954-958.
23. Wang G.T., Chung C.C., Holzman T.F., Krafft G.A. Continuous fluorescence assay of renin activity. Anal. Biochem. 210:1993;351-359.
24. Taliani M., Bianchi E., Narjes F., Fossatelli M., Urbani A., Steinkuhler C., DeFrancesco R., Pessi A. A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. Anal. Biochem. 240:1996;60-67.
25. Pennington M.W., Thornberry N.A. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer. Pept. Res. 7:1994;72-76.
26. Bouvier J., Schneider P., Malcolm B. A fluorescent peptide substrate for the surface metalloprotease of Leishmania. Exp. Parasitol. 76:1993;146-155.
27. Cummings R.T., Salowe S.P., Cunningham B.R., Wiltsie J., Park Y.W., Sonatore L.M., Wisniewski D., Douglas C.M., Hermes J.D., Scolnick E.M. A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease. Proc. Natl. Acad. Sci. USA. 99:2002;6603-6606.
28. Capobianco J.O., Lerner C.G., Goldman R.C. Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase. Anal. Biochem. 204:1992;96-102.
29. Garcia-Echeverria C., Rich D.H. New intramolecularly quenched fluorogenic peptide substrates for the study of the kinetic specificity of papain. FEBS Lett. 297:1992;100-102.
30. Silva A.M., Lee A.Y., Gulnik S.V., Maier P., Collins J., Bhat T.N., Collins P.J., Cachau R.E., Luker K.E., Gluzman I.Y., Francis S.E., Oksman A., Goldberg D.E., Erickson J.W. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. USA. 93:1996;10034-10039.
31. Gopi H.N., Ravindra G., Pal P.P., Pattanaik P., Balaram H., Balaram P. Proteolytic stability of beta-peptide bonds probed using quenched fluorescent substrates incorporating a hemoglobin cleavage site. FEBS Lett. 535:2003;175-178.
32. Salmon B.L., Oksman A., Goldberg D.E. Malaria parasite exit from the host erythrocyte: a two-step process requiring extraerythrocytic proteolysis. Proc. Natl. Acad. Sci. USA. 98:2001;271-276.
33. Greenbaum D.C., Baruch A., Grainger M., Bozdech Z., Medzihradszky K.F., Engel J., DeRisi J., Holder A.A., Bogyo M. A role for the protease falcipain 1 in host cell invasion by the human malaria parasite. Science. 298:2002;2002-2006.
34. Sajid M., Withers-Martinez C., Blackman M.J. Maturation and specificity of Plasmodium falciparum subtilisin-like protease-1, a malaria merozoite subtilisin like serine protease. J. Biol. Chem. 275:2000;631-641.
35. Hackett F., Sajid M., Withers-Martinez C., Grainger M., Blackman M.J. PfSUB-2: a second subtilisin-like protein in Plasmodium falciparum meroziotes. Mol. Biochem. Parasitol. 103:1999;183-195.
36. Braun-Breton C., Rosenberry T.L., da Silva L.P. Induction of the proteolytic activity of a membrane protein in Plasmodium falciparum by phosphatidyl inositol-specific phospholipase C. Nature. 332:1988;457-459.
37. Goldberg D.E., Slater A.F., Beavis R., Chait B., Cerami A., Henderson G.B. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J. Exp. Med. 173:1991;961-969.
38. PlasmoDB: An integrative database of the Plasmodium falciparum genome, Nucleic Acids Res. 29 (2001) 66-69.
39. Coombs G.H., Goldberg D.E., Klemba M., Berry C., Kay J., Mottram J.C. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol. 17:2001;532-537.
40. Le Bonniec S., Deregnaucourt C., Redeker V., Banerjee R., Grellier P., Goldberg D.E., Schrevel J. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole, is active at neutral pH on the host erythrocyte membrane skeleton. J. Biol. Chem. 14:1999;14218-14223.
41. Dua M., Raphael P., Sijwali P.S., Rosenthal P.J., Hanspal M. Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein. Mol. Biochem. Parasitol. 116:2001;95-99.